Biotech Catalyst Monitor - Clinical Trial Readouts & Signals avatar

Biotech Catalyst Monitor - Clinical Trial Readouts & Signals

Pricing

from $200.00 / 1,000 company analyzeds

Go to Apify Store
Biotech Catalyst Monitor - Clinical Trial Readouts & Signals

Biotech Catalyst Monitor - Clinical Trial Readouts & Signals

Track upcoming clinical trial readouts, phase transitions and results from ClinicalTrials.gov, scored by stock-moving impact. A self-serve catalyst signal for biotech investors and traders.

Pricing

from $200.00 / 1,000 company analyzeds

Rating

0.0

(0)

Developer

DataSignals Lab

DataSignals Lab

Maintained by Community

Actor stats

0

Bookmarked

2

Total users

1

Monthly active users

6 hours ago

Last modified

Share

See the trial events that often move biotech stocks, before they happen. Give one or more company names and get their clinical trials from ClinicalTrials.gov, ranked by potential market impact: upcoming Phase 3 readouts, results just posted, and phase transitions. Not a raw trial dump - a curated catalyst dataset.

A single Phase 2 or Phase 3 readout can move a biotech stock 20-80% in a day. This Actor surfaces those catalysts per company, scored and ranked.

Real example (from live data): Moderna - top catalyst: a Phase 3 trial, active, with primary completion 2026-06-30, scored impact 100 (an upcoming readout). Highest-impact events are ranked first.

What makes it different

Most clinical-trial scrapers return raw study records. This one computes the signal:

  • Catalyst classification - upcoming readout, results posted, completed-awaiting-results, or status change.
  • Impact score (0-100) - later phases and near-term readouts rank highest (Phase 3 readout > Phase 1 status note).
  • Per-company ranking - the trials most likely to move the stock, first.
  • Verifiable - every catalyst includes a direct link to the study on ClinicalTrials.gov.

Who it's for

  • Biotech investors and traders - a ready-made trial-catalyst dataset for research and monitoring.
  • Fintech and research apps - drop trial catalysts into your product.
  • Pharma competitive-intelligence teams - track a competitor's pipeline and readout timing.

Pairs with our SEC insider, 13F and 8-K actors for a full market-catalyst suite.

Input

FieldTypeDescription
sponsorsarrayCompany / sponsor names (e.g. Moderna, Vertex Pharmaceuticals, BioNTech).
maxStudiesintegerTrials to scan and rank per company.
minImpactintegerOnly return catalysts at or above this impact score (e.g. 70 = high-impact only).

Output

One item per company: the company query, trials found, a high_impact_count, and a ranked list of catalysts. Each catalyst has the NCT id, title, phase, status, primary completion date, the catalyst type, an impact score, and a direct study URL.

How it works

Reads trials from the official ClinicalTrials.gov v2 API (free, public, no key, JSON). It matches the sponsor field, falls back to full-text when needed, then classifies and scores each trial. Clean, stable, fast - no scraping fragility.

Pricing

Pay-per-event: per company analyzed. Scan a 10-company watchlist = 10 charges. You pay only for what you scan.

FAQ

Which companies can I track? Any sponsor in ClinicalTrials.gov. Use the company name; the Actor matches the sponsor field and falls back to full-text. How current is it? ClinicalTrials.gov is the official U.S. registry, updated continuously; each run reads the latest data.


Keywords: clinical trials, biotech catalyst, trial readout, PDUFA, phase 3 results, ClinicalTrials.gov API, biotech investing, catalyst calendar, drug pipeline, pharma intelligence, biotech catalyst data.


Note: Provided as data for research, screening and monitoring - not investment advice. Historical patterns do not guarantee future results.